| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:535568231:1178 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:535568231:1178?format=raw |
LEADER: 01178cam a22003018a 4500
001 011581616-X
005 20090603011243.0
008 060112s2007 enk 000 0 eng
015 $aGBA614944$2bnb
016 7 $a013381162$2Uk
020 $a1901346927 (pbk.)
020 $a9781901346923 (pbk.)
035 0 $aocn373469632
035 0 $aocm63137324
040 $aUKM$cUKM$dBAKER$dBTCTA$dYDXCP$dVAM$dOCLCG
082 04 $a616.99449$222
090 $aRC280.B8$bB677 2007
245 00 $aBreast cancer /$cedited by Andrew D. Seidman.
260 $aLondon :$bRemedica,$cc2007.
300 $a214 p. :$bill. ;$c21 cm.
505 0 $aAdjuvant endocrine therapy -- Antiestrogens in advanced breast cancer: three decades of progress -- The evolution of adjuvant chemotherapy -- Chemotherapy for metastatic breast cancer -- Trastuzumab in breast cancer treatment -- Targeting angiogenesis in breast cancer treatment -- Targeted therapies on the horizon.
650 22 $aChemotherapy, Adjuvant.
650 12 $aBreast Neoplasms$xtherapy.
650 12 $aBreast Neoplasms$xdrug therapy.
650 0 $aBreast$xCancer.
700 1 $aSeidman, A. D.$q(Andrew D.)
988 $a20081007
906 $0OCLC